Sustainability

Meaningful biopharma sustainability metrics are a crucial challenge.

Biopharma sustainability resolutions for a better 2021.

For many years, high energy use and its impact on the environment by businesses within the life sciences sector had been generally overlooked in national and global efforts to combat climate change. But with “carbon neutrality” the new buzzwords, how is the sector embracing this push for change?

Why major companies are stepping up environmental commitments.

SynBio opens new environmental sustainability possibilities for pharma.

Especially critical amid the continuing global pandemic, key metrics are laid out to help life sciences companies define, measure, and effectively communicate sustainability practices and progress—and build foundations for long-term business value.

Biopharma must find sustainable models for public policy engagement.

ESG objectives are integral to long-term biopharma strategy.

The need for clear transparency around use of real-world data, AI.

Three areas critical to ensuring meaningful long-term action.

Guidance addresses struggles in reporting non-financial performance.

The commercial and social value of non-financial performance.